text: Royal Botanic Garden Edinburgh

characteristic: GAL

text: NOT PROVIDED

text: EarlhamInstitute

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

text: ROYAL BOTANIC GARDEN EDINBURGH

characteristic: barcoding center

text: COPO

characteristic: broker name

text: DAVID BELL | NEIL BELL

text: ROYAL BOTANIC GARDEN EDINBURGH

characteristic: collecting institution

text: United Kingdom

characteristic: geographic location (latitude)

characteristic: geographic location (longitude)

text: Midlothian | Roslin Glen Country Park

characteristic: geographic location (region and locality)

text: Wooded ravine; on soil bank above river

text: DAVID BELL | NEIL BELL

text: ROYAL BOTANIC GARDEN EDINBURGH

text: gametophyte

text: Fissidens taxifolius

characteristic: organism

text: WHOLE ORGANISM

characteristic: organism part

text: DTOL

characteristic: project name

characteristic: sample collection device or method

text: Fissidens taxifolius

text: HERMAPHRODITE MONOECIOUS

text: c3cb58b9-4e84-49ba-b443-a9f882ac3d1f-DTOL-specimen


status: PUBLIC

tag: attribute

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Royal Botanic Garden Edinburgh

text: NOT PROVIDED

text: EarlhamInstitute

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: ROYAL BOTANIC GARDEN EDINBURGH

text: COPO

text: DAVID BELL | NEIL BELL

text: ROYAL BOTANIC GARDEN EDINBURGH

characteristic: collection date

unit: m

characteristic: elevation

text: United Kingdom

characteristic: geographic location (country and/or sea)

unit: DD

text: Midlothian | Roslin Glen Country Park

text: Wooded ravine; on soil bank above river

characteristic: habitat

text: DAVID BELL | NEIL BELL

text: ROYAL BOTANIC GARDEN EDINBURGH

text: gametophyte

characteristic: lifestage

text: Fissidens taxifolius

text: WHOLE ORGANISM

text: DTOL

text: Living plants wild collected into tubs for processing in lab

text: Fissidens taxifolius

text: HERMAPHRODITE MONOECIOUS

characteristic: sex

text: 7bc457bb-d77e-4afd-b49b-cf43459505ef-DTOL-specimen

characteristic: title

characteristic: tolid

characteristic: voucher institution url

type: derived from


text: Royal Botanic Garden Edinburgh

characteristic: GAL

text: NOT PROVIDED

text: EarlhamInstitute

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

text: ROYAL BOTANIC GARDEN EDINBURGH

characteristic: barcoding center

text: COPO

characteristic: broker name

text: DAVID BELL | NEIL BELL

text: ROYAL BOTANIC GARDEN EDINBURGH

characteristic: collecting institution

text: United Kingdom

characteristic: geographic location (latitude)

characteristic: geographic location (longitude)

text: Midlothian | Roslin Glen Country Park

characteristic: geographic location (region and locality)

text: Wooded ravine; on soil bank above river

text: DAVID BELL | NEIL BELL

text: ROYAL BOTANIC GARDEN EDINBURGH

text: gametophyte

text: Fissidens taxifolius

characteristic: organism

text: WHOLE ORGANISM

characteristic: organism part

text: DTOL

characteristic: project name

characteristic: sample collection device or method

text: Fissidens taxifolius

text: HERMAPHRODITE MONOECIOUS

text: bd4ddd5e-51c2-4bba-9394-26b16cf0e2a5-DTOL-specimen


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Royal Botanic Garden Edinburgh

text: NOT PROVIDED

text: EarlhamInstitute

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: ROYAL BOTANIC GARDEN EDINBURGH

text: COPO

text: DAVID BELL | NEIL BELL

text: ROYAL BOTANIC GARDEN EDINBURGH

characteristic: collection date

characteristic: elevation

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: Midlothian | Roslin Glen Country Park

text: Wooded ravine; on soil bank above river

characteristic: habitat

text: DAVID BELL | NEIL BELL

text: ROYAL BOTANIC GARDEN EDINBURGH

text: gametophyte

characteristic: lifestage

text: Fissidens taxifolius

text: WHOLE ORGANISM

text: DTOL

text: Fissidens taxifolius

text: HERMAPHRODITE MONOECIOUS

characteristic: sex

text: 9766703d-c366-4c1a-a6cc-26886bf53b3b-DTOL-specimen

characteristic: title


text: Royal Botanic Garden Edinburgh

characteristic: GAL

text: NOT PROVIDED

text: EarlhamInstitute

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

text: ROYAL BOTANIC GARDEN EDINBURGH

characteristic: barcoding center

text: COPO

characteristic: broker name

text: DAVID BELL | NEIL BELL

text: ROYAL BOTANIC GARDEN EDINBURGH

characteristic: collecting institution

text: United Kingdom

characteristic: geographic location (latitude)

characteristic: geographic location (longitude)

text: Midlothian | Roslin Glen Country Park

characteristic: geographic location (region and locality)

text: Wooded ravine; on soil bank above river

text: DAVID BELL | NEIL BELL

text: ROYAL BOTANIC GARDEN EDINBURGH

text: gametophyte

text: Fissidens taxifolius

characteristic: organism

text: WHOLE ORGANISM

characteristic: organism part

text: DTOL

text: Fissidens taxifolius

text: HERMAPHRODITE MONOECIOUS

text: ccbc11b6-5fce-4e84-908c-6229ca80fa02-DTOL-specimen

characteristic: tolid

characteristic: voucher institution url


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Royal Botanic Garden Edinburgh

text: NOT PROVIDED

text: EarlhamInstitute

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: ROYAL BOTANIC GARDEN EDINBURGH

text: COPO

text: DAVID BELL | NEIL BELL

text: ROYAL BOTANIC GARDEN EDINBURGH

characteristic: collection date

characteristic: elevation

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: Midlothian | Roslin Glen Country Park

text: Wooded ravine; on soil bank above river

characteristic: habitat

text: DAVID BELL | NEIL BELL

text: ROYAL BOTANIC GARDEN EDINBURGH

text: gametophyte

characteristic: lifestage

text: Fissidens taxifolius

text: WHOLE ORGANISM

text: DTOL

characteristic: project name

characteristic: sample collection device or method

text: Fissidens taxifolius

text: HERMAPHRODITE MONOECIOUS

text: 97ac7c1d-d762-46bd-9477-d6297f4292b5-DTOL-specimen


text: Royal Botanic Garden Edinburgh

characteristic: GAL

text: NOT PROVIDED

text: EarlhamInstitute

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

text: ROYAL BOTANIC GARDEN EDINBURGH

characteristic: barcoding center

text: COPO

characteristic: broker name

text: DAVID BELL | DAVID LONG

text: ROYAL BOTANIC GARDEN EDINBURGH

characteristic: collecting institution

text: United Kingdom

characteristic: geographic location (latitude)

characteristic: geographic location (longitude)

text: Berwickshire | Spottiswoode

characteristic: geographic location (region and locality)

text: Edge of birch wood. Base of mossy drystone wall by road

text: DAVID BELL | DAVID LONG

text: ROYAL BOTANIC GARDEN EDINBURGH

text: gametophyte

text: Neoorthocaulis floerkei

characteristic: organism

text: WHOLE ORGANISM

characteristic: organism part

text: DTOL

text: Neoorthocaulis floerkei

text: NOT COLLECTED

characteristic: sex

text: d4121f80-ad65-4b6a-bf3a-c7478d6d8026-DTOL-specimen

characteristic: title


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Royal Botanic Garden Edinburgh

text: NOT PROVIDED

text: EarlhamInstitute

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: ROYAL BOTANIC GARDEN EDINBURGH

text: COPO

text: DAVID BELL | DAVID LONG

text: ROYAL BOTANIC GARDEN EDINBURGH

characteristic: collection date

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: Berwickshire | Spottiswoode

characteristic: habitat

text: DAVID BELL | DAVID LONG

text: ROYAL BOTANIC GARDEN EDINBURGH

text: gametophyte

characteristic: lifestage

text: Neoorthocaulis floerkei

text: WHOLE ORGANISM

text: DTOL

text: Neoorthocaulis floerkei

text: NOT COLLECTED

text: ea9925c8-1112-4656-88d2-6c2fb5f57dfe-DTOL-specimen

characteristic: tolid

characteristic: voucher institution url


text: Royal Botanic Garden Edinburgh

characteristic: GAL

text: NOT PROVIDED

text: EarlhamInstitute

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

text: ROYAL BOTANIC GARDEN EDINBURGH

characteristic: barcoding center

text: COPO

characteristic: broker name

text: DAVID BELL | DAVID LONG

text: ROYAL BOTANIC GARDEN EDINBURGH

characteristic: collecting institution

text: United Kingdom

characteristic: geographic location (latitude)

characteristic: geographic location (longitude)

text: Berwickshire | Spottiswoode

characteristic: geographic location (region and locality)

text: DAVID BELL | DAVID LONG

text: ROYAL BOTANIC GARDEN EDINBURGH

text: gametophyte

text: Neoorthocaulis floerkei

characteristic: organism

text: WHOLE ORGANISM

text: DTOL

characteristic: project name

characteristic: sample collection device or method

text: Neoorthocaulis floerkei

text: NOT COLLECTED

text: 322ae0a6-42b0-4ef2-aca3-b67f40b20a42-DTOL-specimen


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Royal Botanic Garden Edinburgh

text: NOT PROVIDED

text: EarlhamInstitute

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: ROYAL BOTANIC GARDEN EDINBURGH

text: COPO

text: DAVID BELL | DAVID LONG

text: ROYAL BOTANIC GARDEN EDINBURGH

characteristic: collection date

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: Berwickshire | Spottiswoode

characteristic: habitat

text: DAVID BELL | DAVID LONG

text: ROYAL BOTANIC GARDEN EDINBURGH

text: gametophyte

text: Neoorthocaulis floerkei

text: WHOLE ORGANISM

characteristic: organism part

text: DTOL

text: Neoorthocaulis floerkei

text: NOT COLLECTED

characteristic: sex

text: f2713f80-61a9-4106-be95-14b2f073066f-DTOL-specimen

characteristic: title


text: Royal Botanic Garden Edinburgh

characteristic: GAL

text: NOT PROVIDED

text: EarlhamInstitute

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

text: ROYAL BOTANIC GARDEN EDINBURGH

characteristic: barcoding center

text: COPO

characteristic: broker name

text: DAVID BELL | DAVID LONG

text: ROYAL BOTANIC GARDEN EDINBURGH

characteristic: collecting institution

text: United Kingdom

characteristic: geographic location (latitude)

characteristic: geographic location (longitude)

text: Berwickshire | Spottiswoode

characteristic: geographic location (region and locality)

text: DAVID BELL | DAVID LONG

text: ROYAL BOTANIC GARDEN EDINBURGH

text: gametophyte

characteristic: lifestage

text: Neoorthocaulis floerkei

text: WHOLE ORGANISM

text: DTOL

text: Neoorthocaulis floerkei

text: NOT COLLECTED

text: eedd4e95-25ed-4ffd-a12e-c1cb84b7ce30-DTOL-specimen

characteristic: tolid

characteristic: voucher institution url


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Royal Botanic Garden Edinburgh

text: NOT PROVIDED

text: EarlhamInstitute

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: ROYAL BOTANIC GARDEN EDINBURGH

text: COPO

text: DAVID BELL | DAVID LONG

text: ROYAL BOTANIC GARDEN EDINBURGH

characteristic: collection date

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: Berwickshire | Spottiswoode

characteristic: habitat

text: DAVID BELL | DAVID LONG

text: ROYAL BOTANIC GARDEN EDINBURGH

text: gametophyte

text: Neoorthocaulis floerkei

characteristic: organism

text: WHOLE ORGANISM

text: DTOL

characteristic: project name

characteristic: sample collection device or method

text: Neoorthocaulis floerkei

text: NOT COLLECTED

text: 2719f353-7deb-4901-9f71-7e0006b490d5-DTOL-specimen


text: Royal Botanic Garden Edinburgh

characteristic: GAL

text: NOT PROVIDED

text: EarlhamInstitute

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

text: ROYAL BOTANIC GARDEN EDINBURGH

characteristic: barcoding center

text: COPO

characteristic: broker name

text: DAVID BELL | DAVID LONG

text: ROYAL BOTANIC GARDEN EDINBURGH

characteristic: collecting institution

text: United Kingdom

characteristic: geographic location (latitude)

characteristic: geographic location (longitude)

text: Berwickshire | Spottiswoode

characteristic: geographic location (region and locality)

text: DAVID BELL | DAVID LONG

text: ROYAL BOTANIC GARDEN EDINBURGH

text: gametophyte

text: Neoorthocaulis floerkei

text: WHOLE ORGANISM

characteristic: organism part

text: DTOL

text: Neoorthocaulis floerkei

text: NOT COLLECTED

characteristic: sex

text: 45bb2317-2d72-48f6-8b6a-ced0803359d3-DTOL-specimen

characteristic: title


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Royal Botanic Garden Edinburgh

text: NOT PROVIDED

text: EarlhamInstitute

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: ROYAL BOTANIC GARDEN EDINBURGH

text: COPO

text: DAVID BELL | DAVID LONG

text: ROYAL BOTANIC GARDEN EDINBURGH

characteristic: collection date

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: Berwickshire | Spottiswoode

characteristic: habitat

text: DAVID BELL | DAVID LONG

text: ROYAL BOTANIC GARDEN EDINBURGH

text: gametophyte

characteristic: lifestage

text: Neoorthocaulis floerkei

text: WHOLE ORGANISM

text: DTOL

text: Neoorthocaulis floerkei

text: NOT COLLECTED

text: 9c3e5eb9-a688-402f-915c-32a24c61d217-DTOL-specimen

characteristic: tolid

characteristic: voucher institution url


text: Royal Botanic Garden Edinburgh

characteristic: GAL

text: NOT PROVIDED

text: EarlhamInstitute

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

text: ROYAL BOTANIC GARDEN EDINBURGH

characteristic: barcoding center

text: COPO

characteristic: broker name

text: DAVID BELL | DAVID LONG

text: ROYAL BOTANIC GARDEN EDINBURGH

characteristic: collecting institution

text: United Kingdom

characteristic: geographic location (latitude)

characteristic: geographic location (longitude)

text: Berwickshire | Spottiswoode

characteristic: geographic location (region and locality)

text: DAVID BELL | DAVID LONG

text: ROYAL BOTANIC GARDEN EDINBURGH

text: gametophyte

text: Neoorthocaulis floerkei

characteristic: organism

text: WHOLE ORGANISM

text: DTOL

characteristic: project name

characteristic: sample collection device or method

text: Neoorthocaulis floerkei

text: NOT COLLECTED

text: 82710537-da80-4130-a3ac-25d68044a4b0-DTOL-specimen


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Royal Botanic Garden Edinburgh

text: NOT PROVIDED

text: EarlhamInstitute

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: ROYAL BOTANIC GARDEN EDINBURGH

text: COPO

text: DAVID BELL | DAVID LONG

text: ROYAL BOTANIC GARDEN EDINBURGH

characteristic: collection date

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: Berwickshire | Spottiswoode

characteristic: habitat

text: DAVID BELL | DAVID LONG

text: ROYAL BOTANIC GARDEN EDINBURGH

text: gametophyte

text: Neoorthocaulis floerkei

text: WHOLE ORGANISM

characteristic: organism part

text: DTOL

text: Neoorthocaulis floerkei

text: NOT COLLECTED

characteristic: sex

text: 5280cfef-9d7b-4e32-a4d1-f62c2bb68255-DTOL-specimen

characteristic: title


text: Royal Botanic Garden Edinburgh

characteristic: GAL

text: NOT PROVIDED

text: EarlhamInstitute

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

text: ROYAL BOTANIC GARDEN EDINBURGH

characteristic: barcoding center

text: COPO

characteristic: broker name

text: DAVID BELL | DAVID LONG

text: ROYAL BOTANIC GARDEN EDINBURGH

characteristic: collecting institution

text: United Kingdom

characteristic: geographic location (latitude)

characteristic: geographic location (longitude)

text: Berwickshire | Spottiswoode

characteristic: geographic location (region and locality)

text: DAVID BELL | DAVID LONG

text: ROYAL BOTANIC GARDEN EDINBURGH

text: gametophyte

characteristic: lifestage

text: Neoorthocaulis floerkei

text: WHOLE ORGANISM

text: DTOL

text: Living plants wild collected into tubs for processing in lab

text: Neoorthocaulis floerkei

text: NOT COLLECTED

text: 931f3256-68ed-4f1d-88f5-ac1efbde85a4-DTOL-specimen

characteristic: tolid

characteristic: voucher institution url


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Royal Botanic Garden Edinburgh

text: NOT PROVIDED

text: EarlhamInstitute

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: ROYAL BOTANIC GARDEN EDINBURGH

text: COPO

text: DAVID BELL | DAVID LONG

text: ROYAL BOTANIC GARDEN EDINBURGH

characteristic: collection date

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: Berwickshire | Spottiswoode

characteristic: habitat

text: DAVID BELL | DAVID LONG

text: ROYAL BOTANIC GARDEN EDINBURGH

text: gametophyte

text: Neoorthocaulis floerkei

characteristic: organism

text: WHOLE ORGANISM

text: DTOL

characteristic: project name

characteristic: sample collection device or method

text: Neoorthocaulis floerkei

text: NOT COLLECTED

text: 5d8ea0c8-54f8-424c-80bd-7069b06123b5-DTOL-specimen


text: Royal Botanic Garden Edinburgh

characteristic: GAL

text: NOT PROVIDED

text: EarlhamInstitute

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

text: ROYAL BOTANIC GARDEN EDINBURGH

characteristic: barcoding center

text: COPO

characteristic: broker name

text: DAVID BELL | DAVID LONG

text: ROYAL BOTANIC GARDEN EDINBURGH

characteristic: collecting institution

text: United Kingdom

characteristic: geographic location (latitude)

characteristic: geographic location (longitude)

text: Berwickshire | Spottiswoode

characteristic: geographic location (region and locality)

text: DAVID BELL | DAVID LONG

text: ROYAL BOTANIC GARDEN EDINBURGH

text: gametophyte

text: Neoorthocaulis floerkei

text: WHOLE ORGANISM

characteristic: organism part

text: DTOL

text: Neoorthocaulis floerkei

text: NOT COLLECTED

characteristic: sex

text: 06c321ab-3fa9-46ad-946c-89a769700063-DTOL-specimen

characteristic: title


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Royal Botanic Garden Edinburgh

text: NOT PROVIDED

text: EarlhamInstitute

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: ROYAL BOTANIC GARDEN EDINBURGH

text: COPO

text: DAVID BELL | DAVID LONG

text: ROYAL BOTANIC GARDEN EDINBURGH

characteristic: collection date

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: Berwickshire | Spottiswoode

characteristic: habitat

text: DAVID BELL | DAVID LONG

text: ROYAL BOTANIC GARDEN EDINBURGH

text: gametophyte

characteristic: lifestage

text: Neoorthocaulis floerkei

text: WHOLE ORGANISM

text: DTOL

text: Neoorthocaulis floerkei

text: NOT COLLECTED

text: ea71f3fd-57de-4d7e-937e-6b857d422ea0-DTOL-specimen

characteristic: tolid

characteristic: voucher institution url


text: Royal Botanic Garden Edinburgh

characteristic: GAL

text: NOT PROVIDED

text: EarlhamInstitute

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

text: ROYAL BOTANIC GARDEN EDINBURGH

characteristic: barcoding center

text: COPO

characteristic: broker name

text: DAVID BELL | DAVID LONG

text: ROYAL BOTANIC GARDEN EDINBURGH

characteristic: collecting institution

text: United Kingdom

characteristic: geographic location (latitude)

characteristic: geographic location (longitude)

text: Berwickshire | Spottiswoode

characteristic: geographic location (region and locality)

text: DAVID BELL | DAVID LONG

text: ROYAL BOTANIC GARDEN EDINBURGH

text: gametophyte

text: Neoorthocaulis floerkei

characteristic: organism

text: WHOLE ORGANISM

text: DTOL

characteristic: project name

characteristic: sample collection device or method

text: Neoorthocaulis floerkei

text: NOT COLLECTED

text: a01ba4e2-7ebe-47cc-ad11-ce944149862e-DTOL-specimen


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Royal Botanic Garden Edinburgh

text: NOT PROVIDED

text: EarlhamInstitute

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: ROYAL BOTANIC GARDEN EDINBURGH

text: COPO

text: DAVID BELL | DAVID LONG

text: ROYAL BOTANIC GARDEN EDINBURGH

characteristic: collection date

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: Berwickshire | Spottiswoode

text: Edge of birch wood. Base of mossy drystone wall by road

characteristic: habitat

text: DAVID BELL | DAVID LONG

text: ROYAL BOTANIC GARDEN EDINBURGH

text: gametophyte

text: Neoorthocaulis floerkei

text: WHOLE ORGANISM

characteristic: organism part

text: DTOL

text: Neoorthocaulis floerkei

text: NOT COLLECTED

characteristic: sex

text: 182de161-0bc3-4146-9e8e-6cfb2a7ecdd4-DTOL-specimen

characteristic: title


characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

tag: Namespace:Istituto di Ricerche Farmacologiche 'Mario Negri' IRCCS

unit: month

characteristic: age

text: experiment 1

characteristic: batch

text: ArrayExpress

characteristic: broker name

text: not collected

text: house mouse

characteristic: common name

text: Protocols: Age Males WT-Sepn1 Ko-Chop Ko-Sepn1 Ko/Chop Ko OLD: 1 year and 6 months (18months). Age Males WT-Sepn1 Ko-Chop Ko-Sepn1 Ko/Chop Ko YOUNG: 2 months. Age Males WT-Sepn1 Ko-Ero1 Ko-Sepn1 Ko/Ero1 Ko YOUNG: 9 months. The SELENON KO mice were purchased from the EMMA repository (SELENON<tm1.2Mred>/Orl). The CHOP KO mice were purchased (Stock No. 005530) from Jackson Laboratory. The ERO1 alpha KO mice line was resuscitated from the embryos of David Ron’s stock [(Chin, K. T., et al. (2011). "The sarcoplasmic reticulum luminal thiol oxidase ERO1 regulates cardiomyocyte excitation-coupled calcium release and response to hemodynamic load." FASEB J 25(8): 2583-2591]. Fill the becher with isopentane and put it in dry ice in order to reach the correct temperature. Sacrifice the mice by dislocation. Fix the mouse in supine position on the surgical mat by using the needles. Using surgical scissors and forceps, cut the mouse skin to expose the peritoneum. Once that the area is cleaned from hairs, use scissors and forceps to cut the peritoneum. Now that the rib cage and internal organs are exposed, it is necessary to remove everything that is close to the diaphragm (liver, gallbladder, etc). Once that the diaphragm is clearly visible, tilt the rib cage upward using the forceps and cut the diaphragm following the rib cage with the scissors (with a circular movement). Once that the diaphragm is detached from the rib cage, clean it of any residuals by using the forceps. Wash the diaphragm in PBS to remove the blood. Put the diaphragm in cold isopentane in order to instantly freeze the muscle. Store the samples at -80°C. Collection of 5-10 million cells in PDS, and resuspension of the pellet in a buffer. Crumble 50/60mg of muscles by using liquid nitrogen and a pestle. Once that the muscles is mechanically lisate, add 1mL of QIAzol® lysis reagent (by QIAGEN) and put it at -80°C overnight. Extract the RNA the Qiagen RNeasy kit. TruSeq Stranded Total RNA Sample Preparation Guide

characteristic: description

text: adult

characteristic: developmental stage

text: normal

characteristic: disease

text: CHOP -/-

characteristic: genotype

text: not collected

text: not applicable

characteristic: isolate

text: Mus musculus

text: Mus musculus

text: diaphragm

text: Mus musculus

text: male


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Istituto di Ricerche Farmacologiche 'Mario Negri' IRCCS

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: experiment 1

text: ArrayExpress

text: not collected

characteristic: collection date

text: house mouse

text: adult

text: normal

text: CHOP -/-

text: not collected

characteristic: geographic location (country and/or sea)

text: not applicable

text: Mus musculus

characteristic: organism

text: Mus musculus

text: diaphragm

text: Mus musculus

text: male


characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

text: E-MTAB-12460_2:EXP1_OLD_CHOPKO_SEPN1KO_O12

characteristic: age

text: experiment 1

characteristic: batch

text: ArrayExpress

characteristic: broker name

text: not collected

text: house mouse

text: adult

text: normal

text: not collected

text: not applicable

text: Mus musculus

text: Mus musculus

text: diaphragm

characteristic: organism part

text: Mus musculus

text: male

characteristic: sex

characteristic: title


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

text: public

text: E-MTAB-12460_2:EXP1_OLD_CHOPKO_SEPN1KO_O13

text: experiment 1

text: ArrayExpress

text: not collected

text: house mouse

characteristic: common name

characteristic: description

text: adult

characteristic: developmental stage

text: normal

characteristic: disease

characteristic: genotype

text: not collected

text: not applicable

characteristic: isolate

text: Mus musculus

text: Mus musculus

text: diaphragm

text: Mus musculus

text: male


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-12460_2:EXP1_OLD_CHOPKO_SEPN1KO_O14

characteristic: Submitter Id

text: experiment 1

text: ArrayExpress

text: not collected

characteristic: collection date

text: house mouse

text: adult

text: normal

text: not collected

characteristic: geographic location (country and/or sea)

text: not applicable

text: Mus musculus

characteristic: organism

text: Mus musculus

text: diaphragm

text: Mus musculus

text: male


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: INSDC last update

text: public

text: E-MTAB-12460_2:EXP1_OLD_CHOPKO_SEPN1KO_O15

characteristic: age

text: experiment 1

characteristic: batch

text: ArrayExpress

characteristic: broker name

text: not collected

text: house mouse

text: adult

text: normal

text: not collected

text: not applicable

text: Mus musculus

text: Mus musculus

text: diaphragm

characteristic: organism part

text: Mus musculus

text: male

characteristic: sex

characteristic: title


characteristic: ENA-LAST-UPDATE

characteristic: External Id

characteristic: INSDC center name

text: public

text: experiment 1

text: ArrayExpress

text: not collected

text: house mouse

characteristic: common name

characteristic: description

text: adult

characteristic: developmental stage

text: normal

characteristic: disease

text: SELENON<tm1.2Mred>/Orl; CHOP -/-

characteristic: genotype

text: not collected

text: not applicable

characteristic: isolate

text: Mus musculus

text: Mus musculus

text: diaphragm

text: Mus musculus

text: male


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: INSDC first public

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: experiment 1

text: ArrayExpress

text: not collected

characteristic: collection date

text: house mouse

text: adult

text: normal

text: wild type genotype

text: not collected

characteristic: geographic location (country and/or sea)

text: not applicable

text: Mus musculus

characteristic: organism

text: Mus musculus

text: diaphragm

text: Mus musculus

text: male


characteristic: ENA-LAST-UPDATE

characteristic: External Id

characteristic: INSDC last update

text: public

text: E-MTAB-12460_2:EXP1_YOUNG_CHOPKO_SEPN1KO_O32

characteristic: age

text: experiment 1

characteristic: batch

text: ArrayExpress

characteristic: broker name

text: not collected

text: house mouse

text: adult

text: normal

text: not collected

text: not applicable

text: Mus musculus

text: Mus musculus

text: diaphragm

characteristic: organism part

text: Mus musculus

text: male

characteristic: sex

characteristic: title


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: INSDC center name

text: public

text: E-MTAB-12460_2:EXP1_YOUNG_CHOPKO_SEPN1KO_O33

text: experiment 1

text: ArrayExpress

text: not collected

text: house mouse

characteristic: common name

characteristic: description

text: adult

characteristic: developmental stage

text: normal

characteristic: disease

characteristic: genotype

text: not collected

text: not applicable

characteristic: isolate

text: Mus musculus

text: Mus musculus

text: diaphragm

text: Mus musculus

text: male


characteristic: ENA-LAST-UPDATE

characteristic: External Id

characteristic: INSDC first public

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-12460_2:EXP1_YOUNG_CHOPKO_SEPN1KO_O34

characteristic: Submitter Id

text: experiment 1

text: ArrayExpress

text: not collected

characteristic: collection date

text: house mouse

text: adult

text: normal

text: not collected

characteristic: geographic location (country and/or sea)

text: not applicable

text: Mus musculus

characteristic: organism

text: Mus musculus

text: diaphragm

text: Mus musculus

text: male


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: INSDC last update

text: public

text: E-MTAB-12460_2:EXP1_YOUNG_CHOPKO_SEPN1KO_O35

characteristic: age

text: experiment 1

characteristic: batch

text: ArrayExpress

characteristic: broker name

text: not collected

text: house mouse

text: adult

text: normal

text: not collected

text: not applicable

text: Mus musculus

text: Mus musculus

text: diaphragm

characteristic: organism part

text: Mus musculus

text: male

characteristic: sex

characteristic: title


characteristic: ENA-LAST-UPDATE

characteristic: External Id

characteristic: INSDC center name

text: public

text: experiment 2

text: ArrayExpress

text: not collected

text: house mouse

characteristic: common name

characteristic: description

text: adult

characteristic: developmental stage

text: normal

characteristic: disease

text: ERO1 -/-

characteristic: genotype

text: not collected

text: not applicable

characteristic: isolate

text: Mus musculus

text: Mus musculus

text: diaphragm

text: Mus musculus

text: male


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: INSDC first public

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-12460_2:EXP2_YOUNG_ERO1KO_SEPN1KO_O400

characteristic: Submitter Id

text: experiment 2

text: ArrayExpress

text: not collected

characteristic: collection date

text: house mouse

text: adult

text: normal

text: SELENON<tm1.2Mred>/Orl; ERO1 -/-

text: not collected

characteristic: geographic location (country and/or sea)

text: not applicable

text: Mus musculus

characteristic: organism

text: Mus musculus

text: diaphragm

text: Mus musculus

text: male


characteristic: ENA-LAST-UPDATE

characteristic: External Id

characteristic: INSDC last update

text: public

text: E-MTAB-12460_2:EXP2_YOUNG_ERO1KO_SEPN1KO_O401

characteristic: age

text: experiment 2

characteristic: batch

text: ArrayExpress

characteristic: broker name

text: not collected

text: house mouse

text: adult

text: normal

text: SELENON<tm1.2Mred>/Orl; ERO1 -/-

text: not collected

text: not applicable

text: Mus musculus

text: Mus musculus

text: diaphragm

characteristic: organism part

text: Mus musculus

text: male

characteristic: sex

characteristic: title


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: INSDC center name

text: public

text: E-MTAB-12460_2:EXP2_YOUNG_ERO1KO_SEPN1KO_O401a

text: experiment 2

text: ArrayExpress

text: not collected

text: house mouse

characteristic: common name

characteristic: description

text: adult

characteristic: developmental stage

text: normal

characteristic: disease

text: SELENON<tm1.2Mred>/Orl; ERO1 -/-

characteristic: genotype

text: not collected

text: not applicable

characteristic: isolate

text: Mus musculus

text: Mus musculus

text: diaphragm

text: Mus musculus

text: male


characteristic: ENA-LAST-UPDATE

characteristic: External Id

characteristic: INSDC first public

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-12460_2:EXP2_YOUNG_ERO1KO_SEPN1KO_O402

characteristic: Submitter Id

text: experiment 2

text: ArrayExpress

text: not collected

characteristic: collection date

text: house mouse

text: adult

text: normal

text: SELENON<tm1.2Mred>/Orl; ERO1 -/-

text: not collected

characteristic: geographic location (country and/or sea)

text: not applicable

text: Mus musculus

characteristic: organism

text: Mus musculus

text: diaphragm

text: Mus musculus

text: male


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: INSDC last update

text: public

characteristic: age

text: experiment 2

characteristic: batch

text: ArrayExpress

characteristic: broker name

text: not collected

text: house mouse

text: adult

text: normal

text: not collected

text: not applicable

text: Mus musculus

text: Mus musculus

text: diaphragm

characteristic: organism part

text: Mus musculus

text: male

characteristic: sex

characteristic: title


characteristic: ENA-LAST-UPDATE

characteristic: External Id

characteristic: INSDC center name

text: public

text: experiment 2

text: ArrayExpress

text: not collected

text: house mouse

characteristic: common name

characteristic: description

text: adult

characteristic: developmental stage

text: normal

characteristic: disease

text: wild type genotype

characteristic: genotype

text: not collected

text: not applicable

characteristic: isolate

text: Mus musculus

text: Mus musculus

text: diaphragm

text: Mus musculus

text: male


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: SC

characteristic: INSDC first public

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: SC

text: Lighthouse Lab in Glasgow

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: Samples prepared at Lighthouse Lab in Glasgow by Harper VanSteenhouse, Yumi Kasai, David Gray, Carol Clugston, Anna Dominiczak and Alex Alderton, Roberto Amato, Jeffrey Barrett, Sonia Goncalves, Ewan Harrison, David K. Jackson, Ian Johnston, Dominic Kwiatkowski, Cordelia Langford, John Sillitoe on behalf of the Wellcome Sanger Institute COVID-19 Surveillance Team (https://www.sanger.ac.uk/covid-team)

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: Scotland

characteristic: geographic location (region and locality)

text: Human

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

text: Severe acute respiratory syndrome coronavirus 2

characteristic: organism

text: active surveillance in response to outbreak

characteristic: sample capture status


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: SC

characteristic: INSDC center name

characteristic: INSDC last update

text: public

text: SC

characteristic: broker name

text: Lighthouse Lab in Glasgow

text: not provided

characteristic: description

text: United Kingdom

text: England

text: Human

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: isolate

characteristic: title


text: SC

characteristic: INSDC first public

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: SC

text: Rosalind Franklin Laboratory

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: Samples prepared at Rosalind Franklin Laboratory by Donald Fraser, Suki Lee, Rob Howes, The Rosalind Franklin Laboratory and Alex Alderton, Roberto Amato, Jeffrey Barrett, Sonia Goncalves, Ewan Harrison, David K. Jackson, Ian Johnston, Dominic Kwiatkowski, Cordelia Langford, John Sillitoe on behalf of the Wellcome Sanger Institute COVID-19 Surveillance Team

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

characteristic: geographic location (region and locality)

text: Human

characteristic: host common name

text: not provided

text: Human

text: not provided

text: not provided

text: not provided


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: SC

text: public

text: SC

text: Rosalind Franklin Laboratory

text: not provided

text: United Kingdom

text: Wales

text: Human

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: organism

characteristic: sample capture status


text: SC

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: SC

characteristic: broker name

text: Lighthouse Lab in Glasgow

text: not provided

characteristic: description

text: United Kingdom

text: Wales

text: Human

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: isolate

characteristic: title


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: SC

text: public

text: SC

text: Integrated Covid Hub North East

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: Samples prepared at Integrated Covid Hub North East by Integrated Covid Hub North East and Alex Alderton, Roberto Amato, Jeffrey Barrett, Sonia Goncalves, Ewan Harrison, David K. Jackson, Ian Johnston, Dominic Kwiatkowski, Cordelia Langford, John Sillitoe on behalf of the Wellcome Sanger Institute COVID-19 Surveillance Team

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

characteristic: geographic location (region and locality)

text: Human

characteristic: host common name

text: not provided

text: Human

text: not provided

text: not provided

text: not provided


text: SC

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: SC

text: not provided

text: Samples prepared at Berkshire and Surrey Pathology Services Lighthouse Laboratory by Berkshire and Surrey Pathology Services Lighthouse Laboratory and Alex Alderton, Roberto Amato, Jeffrey Barrett, Sonia Goncalves, Ewan Harrison, David K. Jackson, Ian Johnston, Dominic Kwiatkowski, Cordelia Langford, John Sillitoe on behalf of the Wellcome Sanger Institute COVID-19 Surveillance Team

text: United Kingdom

text: England

text: Human

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: organism

characteristic: sample capture status


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: SC

text: public

characteristic: SRA accession

characteristic: Submitter Id

text: SC

characteristic: broker name

text: Berkshire and Surrey Pathology Services Lighthouse Laboratory

text: not provided

characteristic: description

text: United Kingdom

text: England

text: Human

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: isolate

characteristic: title


characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

tag: Namespace:Respiratory Virus Unit, Microbiology Services Colindale, Public Health England

text: COVID-19 Genomics UK Consortium

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: receipt date

text: not provided

characteristic: serotype (required for a seropositive sample)

text: not provided

characteristic: virus identifier


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Respiratory Virus Unit, Microbiology Services Colindale, Public Health England

text: public

characteristic: SRA accession

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: organism

characteristic: sample capture status

text: not provided

text: not provided


text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

tag: Namespace:Oncologica UK Ltd

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: isolate

text: not provided

characteristic: title

text: not provided


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: public

characteristic: SRA accession

characteristic: Submitter Id

text: A. baylyi donor strain (93A2)

characteristic: description

text: France

text: Acinetobacter baylyi

text: Acinetobacter baylyi

text: A. baylyi donor strain (93A2)


characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 02, cycle 20

text: France

text: Acinetobacter baylyi

characteristic: organism

text: Acinetobacter baylyi

text: A. baylyi clone ab93a2_t02


text: public

characteristic: collection date

text: A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 03, cycle 20

text: France

characteristic: geographic location (country and/or sea)

text: Acinetobacter baylyi

text: Acinetobacter baylyi

text: A. baylyi clone ab93a2_t03


text: public

text: A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 04, cycle 20

text: France

text: Acinetobacter baylyi

text: Acinetobacter baylyi

text: A. baylyi clone ab93a2_t04


text: public

text: A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 05, cycle 20

text: France

text: Acinetobacter baylyi

text: Acinetobacter baylyi

text: A. baylyi clone ab93a2_t05


text: public

text: A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 06, cycle 20

text: France

text: Acinetobacter baylyi

text: Acinetobacter baylyi

text: A. baylyi clone ab93a2_t06


text: public

text: A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 07, cycle 20

text: France

text: Acinetobacter baylyi

text: Acinetobacter baylyi

text: A. baylyi clone ab93a2_t07


text: public

text: A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 08, cycle 20

text: France

text: Acinetobacter baylyi

text: Acinetobacter baylyi

text: A. baylyi clone ab93a2_t08


text: public

text: A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 09, cycle 20

text: France

text: Acinetobacter baylyi

text: Acinetobacter baylyi

text: A. baylyi clone ab93a2_t09


text: public

text: A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 11, cycle 20

text: France

text: Acinetobacter baylyi

text: Acinetobacter baylyi

text: A. baylyi clone ab93a2_t11


text: public

text: A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 12, cycle 20

text: France

text: Acinetobacter baylyi

text: Acinetobacter baylyi

text: A. baylyi clone ab93a2_t12


text: public

text: A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 13, cycle 20

text: France

text: Acinetobacter baylyi

text: Acinetobacter baylyi

text: A. baylyi clone ab93a2_t13


text: public

text: A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 14, cycle 20

text: France

text: Acinetobacter baylyi

text: Acinetobacter baylyi

text: A. baylyi clone ab93a2_t14


text: public

text: A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 15, cycle 20

text: France

text: Acinetobacter baylyi

text: Acinetobacter baylyi

text: A. baylyi clone ab93a2_t15


text: public

text: A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 16, cycle 20

text: France

text: Acinetobacter baylyi

text: Acinetobacter baylyi

text: A. baylyi clone ab93a2_t16


text: public

text: A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 17, cycle 20

text: France

text: Acinetobacter baylyi

text: Acinetobacter baylyi

text: A. baylyi clone ab93a2_t17


text: public

text: A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 18, cycle 20

text: France

text: Acinetobacter baylyi

text: Acinetobacter baylyi

text: A. baylyi clone ab93a2_t18


text: public

text: A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 19, cycle 20

text: France

text: Acinetobacter baylyi

text: Acinetobacter baylyi

text: A. baylyi clone ab93a2_t19


text: public

text: A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 20, cycle 20

text: France

text: Acinetobacter baylyi

text: Acinetobacter baylyi

text: A. baylyi clone ab93a2_t20


text: public

text: A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 21, cycle 20

text: France

text: Acinetobacter baylyi

text: Acinetobacter baylyi

text: A. baylyi clone ab93a2_t21


text: public

text: A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 22, cycle 20

text: France

text: Acinetobacter baylyi

text: Acinetobacter baylyi

text: A. baylyi clone ab93a2_t22


text: public

text: A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 23, cycle 20

text: France

text: Acinetobacter baylyi

text: Acinetobacter baylyi

text: A. baylyi clone ab93a2_t23


text: public

text: A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 24, cycle 20

text: France

text: Acinetobacter baylyi

text: Acinetobacter baylyi

text: A. baylyi clone ab93a2_t24


text: public

text: A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 25, cycle 20

text: France

text: Acinetobacter baylyi

text: Acinetobacter baylyi

text: A. baylyi clone ab93a2_t25


text: public

text: A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 26, cycle 20

text: France

text: Acinetobacter baylyi

text: Acinetobacter baylyi

text: A. baylyi clone ab93a2_t26


text: public

text: A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 27, cycle 20

text: France

text: Acinetobacter baylyi

text: Acinetobacter baylyi

text: A. baylyi clone ab93a2_t27


text: public

text: A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 28, cycle 20

text: France

text: Acinetobacter baylyi

text: Acinetobacter baylyi

text: A. baylyi clone ab93a2_t28


text: public

text: A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 29, cycle 20

text: France

text: Acinetobacter baylyi

text: Acinetobacter baylyi

text: A. baylyi clone ab93a2_t29


text: public

text: A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 30, cycle 20

text: France

text: Acinetobacter baylyi

text: Acinetobacter baylyi

text: A. baylyi clone ab93a2_t30


text: public

text: A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 32, cycle 20

text: France

text: Acinetobacter baylyi

text: Acinetobacter baylyi

text: A. baylyi clone ab93a2_t32


text: public

text: A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 33, cycle 20

text: France

text: Acinetobacter baylyi

text: Acinetobacter baylyi

text: A. baylyi clone ab93a2_t33


text: public

text: A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 34, cycle 20

text: France

text: Acinetobacter baylyi

text: Acinetobacter baylyi

text: A. baylyi clone ab93a2_t34


text: public

text: A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 35, cycle 20

text: France

text: Acinetobacter baylyi

text: Acinetobacter baylyi

text: A. baylyi clone ab93a2_t35


text: public

text: A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 36, cycle 20

text: France

text: Acinetobacter baylyi

text: Acinetobacter baylyi

text: A. baylyi clone ab93a2_t36


text: public

text: A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 37, cycle 20

text: France

text: Acinetobacter baylyi

text: Acinetobacter baylyi

text: A. baylyi clone ab93a2_t37


text: public

text: A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 38, cycle 20

text: France

text: Acinetobacter baylyi

text: Acinetobacter baylyi

text: A. baylyi clone ab93a2_t38


text: public

text: A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 39, cycle 20

text: France

text: Acinetobacter baylyi

text: Acinetobacter baylyi

text: A. baylyi clone ab93a2_t39


text: public

text: A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 40, cycle 20

text: France

text: Acinetobacter baylyi

text: Acinetobacter baylyi

text: A. baylyi clone ab93a2_t40


text: public

text: A. baylyi control clone (negative control: no donor DNA; recipient strain ADP1), line 50, cycle 20

text: France

text: Acinetobacter baylyi

text: Acinetobacter baylyi

text: A. baylyi clone ab93a2_t50


text: public

text: B. subtilis transformant clone (donor strain: 2A11T; recipient strain 1A1276), line 01, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 02, cycle 1

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE01; A. baylyi clone AB2A


text: public

text: B. subtilis transformant clone (donor strain: 2A11T; recipient strain 1A1276), line 02, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 02, cycle 2

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE02; A. baylyi clone AB2B


text: public

text: B. subtilis transformant clone (donor strain: 2A11T; recipient strain 1A1276), line 03, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 02, cycle 3

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE03; A. baylyi clone AB2C


text: public

text: B. subtilis transformant clone (donor strain: 2A11T; recipient strain 1A1276), line 04, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 02, cycle 4

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE04; A. baylyi clone AB2D


text: public

text: B. subtilis transformant clone (donor strain: 2A11T; recipient strain 1A1276), line 05, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 02, cycle 5

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE05; A. baylyi clone AB2E


text: public

text: B. subtilis transformant clone (donor strain: 2A11T; recipient strain 1A1276), line 06, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 02, cycle 6

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE06; A. baylyi clone AB2F


text: public

text: B. subtilis transformant clone (donor strain: 2A11T; recipient strain 1A1276), line 08, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 02, cycle 7

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE08; A. baylyi clone AB2G


text: public

text: B. subtilis transformant clone (donor strain: 2A11T; recipient strain 1A1276), line 09, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 02, cycle 8

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE09; A. baylyi clone AB2H


text: public

text: B. subtilis transformant clone (donor strain: 2A11T; recipient strain 1A1276), line 10, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 02, cycle 9

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE10; A. baylyi clone AB2I


text: public

text: B. subtilis transformant clone (donor strain: 2A11T; recipient strain 1A1276), line 11, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 02, cycle 10

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE11; A. baylyi clone AB2J


text: public

text: B. subtilis transformant clone (donor strain: 2A11T; recipient strain 1A1276), line 12, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 02, cycle 11

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE12; A. baylyi clone AB2K


text: public

text: B. subtilis transformant clone (donor strain: 2A11T; recipient strain 1A1276), line 13, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 02, cycle 12

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE13; A. baylyi clone AB2L


text: public

text: B. subtilis transformant clone (donor strain: 2A11T; recipient strain 1A1276), line 14, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 02, cycle 13

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE14; A. baylyi clone AB2M


text: public

text: B. subtilis transformant clone (donor strain: 2A11T; recipient strain 1A1276), line 15, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 02, cycle 14

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE15; A. baylyi clone AB2N


text: public

text: B. subtilis transformant clone (donor strain: 2A11T; recipient strain 1A1276), line 16, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 02, cycle 15

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE16; A. baylyi clone AB2O


text: public

text: B. subtilis transformant clone (donor strain: 2A11T; recipient strain 1A1276), line 17, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 02, cycle 16

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE17; A. baylyi clone AB2P


text: public

text: B. subtilis transformant clone (donor strain: 2A11T; recipient strain 1A1276), line 18, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 02, cycle 17

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE18; A. baylyi clone AB2Q


text: public

text: B. subtilis transformant clone (donor strain: 2A11T; recipient strain 1A1276), line 19, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 02, cycle 18

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE19; A. baylyi clone AB2R


text: public

text: B. subtilis transformant clone (donor strain: 2A11T; recipient strain 1A1276), line 20, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 02, cycle 19

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE20; A. baylyi clone AB2S


text: public

text: B. subtilis transformant clone (donor strain: 2A11T; recipient strain 1A1276), line 21, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 02, cycle 20

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE21; A. baylyi clone AB2T


text: public

text: B. subtilis transformant clone (donor strain: 2A11T; recipient strain 1A1276), line 22, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 13, cycle 1

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE22; A. baylyi clone AB13A


text: public

text: B. subtilis transformant clone (donor strain: 2A11T; recipient strain 1A1276), line 23, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 13, cycle 2

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE23; A. baylyi clone AB13B


text: public

text: B. subtilis transformant clone (donor strain: 2A11T; recipient strain 1A1276), line 24, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 13, cycle 3

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE24; A. baylyi clone AB13C


text: public

text: B. subtilis transformant clone (donor strain: 2A11T; recipient strain 1A1276), line 25, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 13, cycle 4

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE25; A. baylyi clone AB13D


text: public

text: B. subtilis transformant clone (donor strain: 2A11T; recipient strain 1A1276), line 26, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 13, cycle 5

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE26; A. baylyi clone AB13E


text: public

text: B. subtilis transformant clone (donor strain: 2A11T; recipient strain 1A1276), line 27, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 13, cycle 6

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE27; A. baylyi clone AB13F


text: public

text: B. subtilis transformant clone (donor strain: 2A11T; recipient strain 1A1276), line 28, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 13, cycle 7

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE28; A. baylyi clone AB13G


text: public

text: B. subtilis transformant clone (donor strain: 2A11T; recipient strain 1A1276), line 29, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 13, cycle 8

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE29; A. baylyi clone AB13H


text: public

text: B. subtilis transformant clone (donor strain: 2A11T; recipient strain 1A1276), line 30, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 13, cycle 9

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE30; A. baylyi clone AB13I


text: public

text: B. subtilis transformant clone (donor strain: 2A11T; recipient strain 1A1276), line 31, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 13, cycle 10

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE31; A. baylyi clone AB13J


text: public

text: B. subtilis transformant clone (donor strain: 2A11T; recipient strain 1A1276), line 32, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 13, cycle 11

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE32; A. baylyi clone AB13K


text: public

text: B. subtilis transformant clone (donor strain: 2A11T; recipient strain 1A1276), line 33, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 13, cycle 12

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE33; A. baylyi clone AB13L


text: public

text: B. subtilis transformant clone (donor strain: 2A11T; recipient strain 1A1276), line 34, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 13, cycle 13

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE34; A. baylyi clone AB13M


text: public

text: B. subtilis transformant clone (donor strain: 2A11T; recipient strain 1A1276), line 35, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 13, cycle 14

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE35; A. baylyi clone AB13N


text: public

text: B. subtilis transformant clone (donor strain: 2A11T; recipient strain 1A1276), line 36, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 13, cycle 15

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE36; A. baylyi clone AB13O


text: public

text: B. subtilis transformant clone (donor strain: 2A11T; recipient strain 1A1276), line 37, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 13, cycle 16

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE37; A. baylyi clone AB13P


text: public

text: B. subtilis transformant clone (donor strain: 2A11T; recipient strain 1A1276), line 38, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 13, cycle 17

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE38; A. baylyi clone AB13Q


text: public

text: B. subtilis transformant clone (donor strain: 2A11T; recipient strain 1A1276), line 39, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 13, cycle 18

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE39; A. baylyi clone AB13R


text: public

text: B. subtilis transformant clone (donor strain: 2A11T; recipient strain 1A1276), line 40, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 13, cycle 19

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE40; A. baylyi clone AB13S


text: public

text: B. subtilis transformant clone (donor strain: 2A11T; recipient strain 1A1276), line 41, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 13, cycle 20

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE41; A. baylyi clone AB13T


text: public

text: B. subtilis transformant clone (donor strain: 2A11T; recipient strain 1A1276), line 42, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 02, cycle 20 (additional clone 1)

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE42; A. baylyi clone AB2T1


text: public

text: B. subtilis transformant clone (donor strain: 2A11T; recipient strain 1A1276), line 43, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 02, cycle 20 (additional clone 2)

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE43; A. baylyi clone AB2T2


text: public

text: B. subtilis transformant clone (donor strain: 2A11T; recipient strain 1A1276), line 44, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 02, cycle 20 (additional clone 3)

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE44; A. baylyi clone AB2T3


text: public

text: B. subtilis transformant clone (donor strain: 2A11T; recipient strain 1A1276), line 45, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 02, cycle 20 (additional clone 4)

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE45; A. baylyi clone AB2T4


text: public

text: B. subtilis control clone (negative control: no donor DNA; recipient strain 1A1276), line 48, cycle 20 ; A. baylyi transformant clone (donor strain: 93A2; recipient strain ADP1), line 02, cycle 20 (additional clone 7)

text: France

text: mixed culture bacterium

text: mixed culture bacterium

text: DNA pool: B. subtilis clone BSE48; A. baylyi clone AB2T7


text: INSTITUT PASTEUR

text: public

tag: Namespace:INSTITUT PASTEUR

text: not provided

text: nasopharyngeal swab

text: France

text: Human

characteristic: host

text: Human coronavirus OC43

text: Human coronavirus OC43


COG-UK/DHSC-CYDCUZZ

text: Yourgene Health

text: public

text: COG-UK/DHSC-CYDCUZZ

tag: Namespace:Yourgene Health

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Yourgene Health

characteristic: collecting institution

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

text: Severe acute respiratory syndrome coronavirus 2

text: active surveillance in response to outbreak

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYDCUZZ

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYDBUHD

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Yourgene Health

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYDBUHD

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

text: Yourgene Health

characteristic: collection date

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYDBUHD

characteristic: title

text: not provided


COG-UK/DHSC-CYBINXE

text: Yourgene Health

text: public

text: COG-UK/DHSC-CYBINXE

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Yourgene Health

characteristic: collecting institution

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

text: not provided

text: COG-UK/DHSC-CYBINXE

text: not provided


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYNIRIA

text: Yourgene Health

text: public

text: COG-UK/DHSC-CYNIRIA

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Yourgene Health

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

text: not provided

text: not provided

text: not provided

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYNIRIA

characteristic: title

text: not provided


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Yourgene Health

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: COVID-19 Genomics UK Consortium

text: Yourgene Health

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

characteristic: host scientific name

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

text: not provided

text: not provided


COG-UK/DHSC-CYBZUUK

text: Oncologica UK Ltd

text: public

characteristic: SRA accession

text: COG-UK/DHSC-CYBZUUK

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

characteristic: geographic location (region and locality)

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYBZUUK

text: not provided

characteristic: virus identifier


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Yourgene Health

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: COVID-19 Genomics UK Consortium

text: Yourgene Health

text: not provided

text: not provided

text: United Kingdom

text: Scotland

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

text: not provided

text: not provided

text: not provided

characteristic: organism

text: not provided

characteristic: title

text: not provided


COG-UK/DHSC-CYDUQDS

text: Yourgene Health

text: public

characteristic: SRA accession

text: COG-UK/DHSC-CYDUQDS

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Yourgene Health

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

characteristic: host scientific name

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

text: not provided

text: COG-UK/DHSC-CYDUQDS

text: not provided


COG-UK/DHSC-CYNBJAS

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: COG-UK/DHSC-CYNBJAS

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

characteristic: geographic location (region and locality)

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYNBJAS

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYBJGIO

text: Oncologica UK Ltd

text: public

characteristic: SRA accession

text: COG-UK/DHSC-CYBJGIO

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

text: not provided

text: not provided

text: not provided

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYBJGIO

characteristic: title

text: not provided


COG-UK/DHSC-CYNURMT

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: COG-UK/DHSC-CYNURMT

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

characteristic: host scientific name

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

text: not provided

text: COG-UK/DHSC-CYNURMT

text: not provided


COG-UK/DHSC-CYDJUNE

text: Yourgene Health

text: public

characteristic: SRA accession

text: COG-UK/DHSC-CYDJUNE

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Yourgene Health

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

characteristic: geographic location (region and locality)

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYDJUNE

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYBKBME

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: COG-UK/DHSC-CYBKBME

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

text: not provided

text: not provided

text: not provided

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYBKBME

characteristic: title

text: not provided


COG-UK/DHSC-CYYEDXD

text: Yourgene Health

text: public

characteristic: SRA accession

text: COG-UK/DHSC-CYYEDXD

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Yourgene Health

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

characteristic: host scientific name

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

text: not provided

text: COG-UK/DHSC-CYYEDXD

text: not provided


COG-UK/DHSC-CYBCWKU

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Yourgene Health

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: COG-UK/DHSC-CYBCWKU

text: COVID-19 Genomics UK Consortium

text: Yourgene Health

text: not provided

text: not provided

text: United Kingdom

text: England

characteristic: geographic location (region and locality)

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYBCWKU

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYDBQHE

text: Oncologica UK Ltd

text: public

characteristic: SRA accession

text: COG-UK/DHSC-CYDBQHE

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

text: not provided

text: not provided

text: not provided

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYDBQHE

characteristic: title

text: not provided


COG-UK/DHSC-CYYKXSR

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: COG-UK/DHSC-CYYKXSR

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

characteristic: host scientific name

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

text: not provided

text: COG-UK/DHSC-CYYKXSR

text: not provided


COG-UK/DHSC-CYBOEXC

text: Oncologica UK Ltd

text: public

characteristic: SRA accession

text: COG-UK/DHSC-CYBOEXC

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

characteristic: geographic location (region and locality)

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYBOEXC

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYBWZJB

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: COG-UK/DHSC-CYBWZJB

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

text: not provided

text: not provided

text: not provided

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYBWZJB

characteristic: title

text: not provided


text: Oncologica UK Ltd

text: public

characteristic: SRA accession

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

characteristic: host scientific name

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

text: not provided

text: not provided


COG-UK/DHSC-CYBCSOR

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: COG-UK/DHSC-CYBCSOR

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

characteristic: geographic location (region and locality)

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYBCSOR

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYDKBWU

text: Oncologica UK Ltd

text: public

characteristic: SRA accession

text: COG-UK/DHSC-CYDKBWU

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

text: not provided

text: not provided

text: not provided

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYDKBWU

characteristic: title

text: not provided


COG-UK/DHSC-CYDZAKS

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Yourgene Health

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: COG-UK/DHSC-CYDZAKS

text: COVID-19 Genomics UK Consortium

text: Yourgene Health

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

characteristic: host scientific name

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

text: not provided

text: COG-UK/DHSC-CYDZAKS

text: not provided


COG-UK/DHSC-CYBWMQD

text: Oncologica UK Ltd

text: public

characteristic: SRA accession

text: COG-UK/DHSC-CYBWMQD

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

characteristic: geographic location (region and locality)

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYBWMQD

text: not provided

characteristic: virus identifier


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Yourgene Health

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: COVID-19 Genomics UK Consortium

text: Yourgene Health

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

text: not provided

text: not provided

text: not provided

characteristic: organism

text: not provided

characteristic: title

text: not provided


COG-UK/DHSC-CYYQWHM

text: Oncologica UK Ltd

text: public

characteristic: SRA accession

text: COG-UK/DHSC-CYYQWHM

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

characteristic: host scientific name

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

text: not provided

text: COG-UK/DHSC-CYYQWHM

text: not provided


COG-UK/DHSC-CYDSPSK

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Yourgene Health

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: COG-UK/DHSC-CYDSPSK

text: COVID-19 Genomics UK Consortium

text: Yourgene Health

text: not provided

text: not provided

text: United Kingdom

text: England

characteristic: geographic location (region and locality)

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYDSPSK

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYBONRE

text: Yourgene Health

text: public

characteristic: SRA accession

text: COG-UK/DHSC-CYBONRE

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Yourgene Health

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

text: not provided

text: not provided

text: not provided

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYBONRE

characteristic: title

text: not provided


COG-UK/DHSC-CYYKGXH

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Yourgene Health

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: COG-UK/DHSC-CYYKGXH

text: COVID-19 Genomics UK Consortium

text: Yourgene Health

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

characteristic: host scientific name

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

text: not provided

text: COG-UK/DHSC-CYYKGXH

text: not provided


COG-UK/DHSC-CYNOPZI

text: Oncologica UK Ltd

text: public

characteristic: SRA accession

text: COG-UK/DHSC-CYNOPZI

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

characteristic: geographic location (region and locality)

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYNOPZI

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYDRIUP

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Yourgene Health

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: COG-UK/DHSC-CYDRIUP

text: COVID-19 Genomics UK Consortium

text: Yourgene Health

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

text: not provided

text: not provided

text: not provided

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYDRIUP

characteristic: title

text: not provided


COG-UK/DHSC-CYNDZJD

text: Yourgene Health

text: public

characteristic: SRA accession

text: COG-UK/DHSC-CYNDZJD

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Yourgene Health

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

characteristic: host scientific name

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

text: not provided

text: COG-UK/DHSC-CYNDZJD

text: not provided


COG-UK/DHSC-CYBSMTA

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Yourgene Health

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: COG-UK/DHSC-CYBSMTA

text: COVID-19 Genomics UK Consortium

text: Yourgene Health

text: not provided

text: not provided

text: United Kingdom

text: England

characteristic: geographic location (region and locality)

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYBSMTA

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYDTHJY

text: Oncologica UK Ltd

text: public

characteristic: SRA accession

text: COG-UK/DHSC-CYDTHJY

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

text: not provided

text: not provided

text: not provided

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYDTHJY

characteristic: title

text: not provided


COG-UK/DHSC-CYYTZHB

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: COG-UK/DHSC-CYYTZHB

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

characteristic: host scientific name

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

text: not provided

text: COG-UK/DHSC-CYYTZHB

text: not provided